278 studies found for:    Recruiting | Exclude Unknown | NIDDK
Show Display Options
Rank Status Study
1 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
2 Recruiting Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir;   Drug: Peginterferon-alfa 2a and tenofovir
3 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
4 Recruiting Low-Dose Leptin and the Formerly-Obese
Condition: Obesity
Interventions: Drug: Leptin;   Behavioral: Dietary modification;   Drug: T3 repletion
5 Recruiting Biliary Atresia Study in Infants and Children
Condition: Biliary Atresia
Intervention:
6 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
7 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
8 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
9 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
Intervention:
10 Recruiting Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Condition: Gastroparesis
Interventions: Drug: Aprepitant;   Drug: Placebo
11 Recruiting Tamsulosin for Urolithiasis in the Emergency Dept
Condition: Nephrolithiasis
Intervention: Drug: tamsulosin
12 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
13 Recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG)/Placebo;   Drug: Granulocyte colony stimulating factor (GCSF)
14 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
15 Recruiting Home-Based Interventions for Adolescents With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Behavioral: Fit Families plus Standard Medical Care;   Behavioral: Standard Medical Care
16 Recruiting TODAY Genetics Study
Condition: Type 2 Diabetes
Intervention:
17 Recruiting Gastroparesis Registry 2
Conditions: Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:
18 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
19 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
20 Recruiting Longitudinal Study of Mitochondrial Hepatopathies
Conditions: Acute Liver Failure,;   Mitochondrial Diseases;   End Stage Liver Disease,;   Respiratory Chain Deficiencies, Mitochondrial;   Disorder of Fatty Acid Oxidation
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years